Miriam Sharon Rose, MD | |
4060 Sw 110th Ave, Beaverton, OR 97005-3017 | |
(503) 819-1215 | |
Not Available |
Full Name | Miriam Sharon Rose |
---|---|
Gender | Female |
Speciality | Neuromusculoskeletal Medicine & Omm |
Location | 4060 Sw 110th Ave, Beaverton, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770812943 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | MD27475 (Oregon) | Secondary |
204D00000X | Neuromusculoskeletal Medicine & Omm | MD27475 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miriam Sharon Rose, MD 4060 Sw 110th Ave, Beaverton, OR 97005-3017 Ph: (503) 819-1215 | Miriam Sharon Rose, MD 4060 Sw 110th Ave, Beaverton, OR 97005-3017 Ph: (503) 819-1215 |
News Archive
The average low-income person loses 8.2 years of perfect health, the average high school dropout loses 5.1 years, and the obese lose 4.2 years, according to researchers at Columbia University's Mailman School of Public Health. Tobacco control has long been one of the most important public health policies, and rightly so; the average smoker loses 6.6 years of perfect health to their habit.
Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy in treating cancer. They are presenting results of their preclinical research at the 2018 annual meeting of the American Society of Hematology in San Diego.
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
Healthline Networks, the leading provider of intelligent health information services, and MedHelp, the world's largest health social network and the leading provider of online and mobile health applications, today announced an expansion of their strategic partnership, naming Healthline as the exclusive third-party representative for custom content programs for selected pharmaceutical advertisers on MedHelp.
› Verified 2 days ago